Dr. Kaitin joined the Tufts Center for the Study of Drug Development in 1986 and has served as its Director since 1998. He is also a Professor of Medicine and Professor of Pharmacology & Experimental Therapeutics at Tufts University School of Medicine. Dr. Kaitin is an internationally recognized expert on the science of drug development. He publishes extensively on the factors that contribute to the slow pace and high cost of pharmaceutical R&D, and he has provided public testimony before the U.S. Congress on drug development, regulation, and policy issues. Dr. Kaitin is frequently quoted in the business and trade press on R&D trends in the research-based pharmaceutical and biotechnology industries. His work covers the entire value chain of pharmaceutical innovation, from discovery to manufacturing and sales and marketing. Dr. Kaitin is a former president of the Drug Information Association and editor-in-chief of the Drug Information Journal. He currently serves on the editorial boards of eight peer-reviewed and trade journals. He also serves on the Boards of Directors of two public companies and one private company, and the Scientific Advisory Boards of two companies. He received a B.S. from Cornell University and an M.S. and Ph.D. in pharmacology from the University of Rochester.